Key Takeaways. Draft guidance targets reduction/elimination of nonhuman primate testing for monoclonal antibodies, signaling higher regulatory receptivity to alternative nonclinic ...
The CDMO industry is undergoing a fundamental transformation, driven by the growing complexity of new drug modalities ...
Pharmaceutical importers benefit directly because IEEPA-derived tariffs on finished drugs and ingredients are refund-eligible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results